Quality and documentation
Aurastin uses the public catalog to establish product direction. Technical documents are reviewed against the proposed formula, packaging format, target market, and qualification stage.
Buyers may request a product specification, packaging options, COA and MSDS path, or a private-label discussion through the RFQ form.
Document availability and release conditions are confirmed per project. The public catalog does not represent a final batch specification.
The first review aligns category, intended format, target market, packaging, and the documents needed for the next decision.
Final manufacturing and batch documents are issued only after the relevant formula and project scope are approved.
Public pages use cosmetic and wellness language only. Aurastin does not publish disease, drug, injectable, dosage, or treatment claims on this catalog.
